Navigation Links
Novel Technique For Identification And Treatment Of Neurodegenerative Diseases

A new technique has been developed to identify and localize the presence of tiny iron oxide particles associated with neurodegenerative disorders, more specifically Alzheimer's. // The finding could eventually pave way for the development of a first real time diagnostic procedure for Alzheimer's.

The identification is based on equipment called synchrotron, (a device that accelerates electrons to produce high intensity X-rays). The equipment has numerous applications in the physics related experiments. The researchers from University of Florida incorporated lenses and mirrors to the usual set up to enable analysis of brain tissue. The depth of examination and precision are main advantages of this device.

The electron microscope can provide adequate resolution of 1 micron (1/1000th of a centimeter). The new device can allow identification and subsequent examination of particles as small as 200-300 microns in size. 'It's the equivalent of being up in an airplane, looking at the city of Tampa, and telling you whether there is a penny there or not. And then once we zoom in, we can tell you what kind of penny it is,' remarked Dr. Davidson, one of the senior researchers.

Diseases such as Alzheimer's, Parkinson's and Huntington's affect millions worldwide and pose a significant strain on the financial resources. The number is only expected to increase in the forthcoming years. All these diseases share some common features such as dementia and physical impairment. It is also known that specific brain regions afflicted with the above-mentioned disorders are likely to contain elevated levels of iron oxide and other iron particles.

Currently, the role of iron in neurodegenerative disorders is poorly understood. It is known that iron is essential for normal functioning of the brain. Consistent with the above fact, small amounts of iron is present in healthy brains as well.

It is unclear if iron causes such disorders or iron depos ition is a characteristic symptom of the same. The new technique could accelerate research on the cause of such neurodegenerative disorders.

Conventional methods used for identification of such iron particles rely on staining of tissue sections. The disadvantage of these methods is that it does not highlight the presence of specific compounds of iron. In addition, it is also not possible to relate iron compounds to specific regions of the brain.

An improved understanding of the disease process could lead to effective treatment strategies in the years to come. The researchers further intend to explore if magnetic resonance imaging (MRI) can be used to highlight 'iron induced brain damage' in affected patients.


'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/18/2019)... SCOTCH PLAINS, N.J. (PRWEB) , ... September 18, ... ... Michael L. Scagnelli, DMD for the fourth consecutive year. Dr. Scagnelli specializes in ... Matawan-based practice was established in the 1940’s and has been delivering quality dental ...
(Date:9/17/2019)... ... 17, 2019 , ... Six Consulting Inc. (SIX) recently announced ... – specifically golden retrievers - through innovative cancer prevention medicine. A national survey ... out of five retrievers in the United States will die from a particular ...
(Date:9/17/2019)... ... ... Lubin Austermuehle, P.C. will be one of the sponsors of GRIN2B ... Found Kitchen and Social House in Evanston on Monday, October 7 from 6 p.m. ... rare condition that results from changes to the GRIN2B gene. The GRIN2B gene is ...
(Date:9/17/2019)... LYNDHURST, N.J. (PRWEB) , ... September 17, 2019 ... ... in a wide array of services, welcomes Dr. Yevgeniya (Jenny) Gartshteyn to their ... University Medical Center, where she previously held the Clinical Appointment of Assistant Professor ...
(Date:9/11/2019)... ... September 12, 2019 , ... “Heart Seizures”: a useful source of ... disease as he hopes to prevent anyone from having it and to help those ... Saltwick, a writer who was diagnosed with coronary artery disease. Predicted to experience another ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... ... September 13, 2019 , ... St. Joseph’s Hospital, Robins ... the structural topping out of the St. Joseph’s Hospital patient tower expansion located ... new six-story patient tower that will house a two-story lobby, waiting and on-call ...
(Date:9/12/2019)... ... ... Stratosphere Networks will sponsor GRIN2B Foundation’s first cocktail reception fundraiser, ... at Found Kitchen and Social House in Evanston from 6 p.m. to 9 p.m. ... is a gene on the short arm of the 12th chromosome and is part ...
(Date:9/11/2019)... ... 12, 2019 , ... Understanding the Drug Supply Chain Security ... Sept. 26, 2019, 1:30-3:00 p.m. EDT, https://www.fdanews.com/understanding-the-dscsa , Need to comply ... clear on nuances of the guidelines regulating the drug supply chain? , ...
Breaking Medicine Technology: